Abstract

Most studies of cohesin function consider the Stromalin Antigen (STAG/SA) proteins as core complex members given their ubiquitous interaction with the cohesin ring. Here, we provide functional data to support the notion that the SA subunit is not a mere passenger in this structure, but instead plays a key role in the localization of cohesin to diverse biological processes and promotes loading of the complex at these sites. We show that in cells acutely depleted for RAD21, SA proteins remain bound to chromatin, cluster in 3D and interact with CTCF, as well as with a wide range of RNA binding proteins involved in multiple RNA processing mechanisms. Accordingly, SA proteins interact with RNA, RNA binding proteins and R-loops, even in the absence of cohesin. Our results place SA1 on chromatin upstream of the cohesin ring and reveal a role for SA1 in cohesin loading which is independent of NIPBL, the canonical cohesin loader. We propose that SA1 takes advantage of structural R-loop platforms to link cohesin loading and chromatin structure with diverse functions. Since SA proteins are pan-cancer targets, and R-loops play an increasingly prevalent role in cancer biology, our results have important implications for the mechanistic understanding of SA proteins in cancer and disease.

Data availability

All data has been made freely available. Please see Page 21 of the manuscript for Accession numbers.

The following data sets were generated

Article and author information

Author details

  1. Hayley Porter

    Research Department of Cancer Biology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Yang Li

    Research Department of Cancer Biology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Maria Victoria  Neguembor

    Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1583-1304
  4. Manuel Beltran

    Regulatory Genomics Group, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Wazeer Varsally

    Research Department of Cancer Biology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Laura Martin

    Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8801-6637
  7. Manuel Tavares Cornejo

    Regulatory Genomics Group, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Dubravka Pezic

    Research Department of Cancer Biology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Amandeep Bhamra

    Proteomics Research, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Silvia Surinova

    Proteomics Research, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Richard G Jenner

    Regulatory Genomics Group, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Maria Pia Cosma

    Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4207-5097
  13. Suzana Hadjur

    Research Department of Cancer Biology, University College London, London, United Kingdom
    For correspondence
    s.hadjur@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3146-3118

Funding

Wellcome Trust (106985/Z/15/Z)

  • Suzana Hadjur

Cancer Research UK (PhD studentship)

  • Hayley Porter

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Andrés Aguilera, CABIMER, Universidad de Sevilla, Spain

Version history

  1. Preprint posted: February 20, 2021 (view preprint)
  2. Received: April 10, 2022
  3. Accepted: April 2, 2023
  4. Accepted Manuscript published: April 3, 2023 (version 1)
  5. Version of Record published: June 2, 2023 (version 2)

Copyright

© 2023, Porter et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,037
    views
  • 441
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hayley Porter
  2. Yang Li
  3. Maria Victoria  Neguembor
  4. Manuel Beltran
  5. Wazeer Varsally
  6. Laura Martin
  7. Manuel Tavares Cornejo
  8. Dubravka Pezic
  9. Amandeep Bhamra
  10. Silvia Surinova
  11. Richard G Jenner
  12. Maria Pia Cosma
  13. Suzana Hadjur
(2023)
Cohesin-independent STAG proteins interact with RNA and R-loops and promote complex loading
eLife 12:e79386.
https://doi.org/10.7554/eLife.79386

Share this article

https://doi.org/10.7554/eLife.79386

Further reading

    1. Cancer Biology
    2. Cell Biology
    Julian JA Hoving, Elizabeth Harford-Wright ... Alison C Lloyd
    Research Article Updated

    Collective cell migration is fundamental for the development of organisms and in the adult for tissue regeneration and in pathological conditions such as cancer. Migration as a coherent group requires the maintenance of cell–cell interactions, while contact inhibition of locomotion (CIL), a local repulsive force, can propel the group forward. Here we show that the cell–cell interaction molecule, N-cadherin, regulates both adhesion and repulsion processes during Schwann cell (SC) collective migration, which is required for peripheral nerve regeneration. However, distinct from its role in cell–cell adhesion, the repulsion process is independent of N-cadherin trans-homodimerisation and the associated adherens junction complex. Rather, the extracellular domain of N-cadherin is required to present the repulsive Slit2/Slit3 signal at the cell surface. Inhibiting Slit2/Slit3 signalling inhibits CIL and subsequently collective SC migration, resulting in adherent, nonmigratory cell clusters. Moreover, analysis of ex vivo explants from mice following sciatic nerve injury showed that inhibition of Slit2 decreased SC collective migration and increased clustering of SCs within the nerve bridge. These findings provide insight into how opposing signals can mediate collective cell migration and how CIL pathways are promising targets for inhibiting pathological cell migration.

    1. Cell Biology
    2. Neuroscience
    Marcos Moreno-Aguilera, Alba M Neher ... Carme Gallego
    Research Article Updated

    Alternative RNA splicing is an essential and dynamic process in neuronal differentiation and synapse maturation, and dysregulation of this process has been associated with neurodegenerative diseases. Recent studies have revealed the importance of RNA-binding proteins in the regulation of neuronal splicing programs. However, the molecular mechanisms involved in the control of these splicing regulators are still unclear. Here, we show that KIS, a kinase upregulated in the developmental brain, imposes a genome-wide alteration in exon usage during neuronal differentiation in mice. KIS contains a protein-recognition domain common to spliceosomal components and phosphorylates PTBP2, counteracting the role of this splicing factor in exon exclusion. At the molecular level, phosphorylation of unstructured domains within PTBP2 causes its dissociation from two co-regulators, Matrin3 and hnRNPM, and hinders the RNA-binding capability of the complex. Furthermore, KIS and PTBP2 display strong and opposing functional interactions in synaptic spine emergence and maturation. Taken together, our data uncover a post-translational control of splicing regulators that link transcriptional and alternative exon usage programs in neuronal development.